Figure 1.
Serum alkaline phosphatase levels in NOD.c3c4 receiving no antiretroviral therapy. (A) Serial measurement of serum alkaline phosphatase in the NOD.c3c4 mice showing variance in individual levels as well as a reduction mean levels as mice aged, mainly from 8 to 12 weeks (P < 0.0001, 1 way anova). (B) Reduction in serum alkaline phosphatase levels from baseline levels between 8 and 12 weeks, showing diminished reduction in NOD.c3c4 vs. NOD.GFP (Data shown as means ± SEM, ***P < 0.001, t-test).